SEC Company Response from HEMOSENSE INC (CIK 0001127393) — Jun 13, 2005
HEMOSENSE INC (CIK 0001127393)
Date: June 13, 2005 · CIK: 0001127393 · Accession: 0001193125-05-124527
AI Filing Summary & Sentiment
File numbers found in text: 333-123705
Letter
Via EDGAR Transmission and Facsimile Securities and Exchange Commission Division of Corporation Finance Attention: Mary Beth Breslin Re: HemoSense, Inc. (File No. 333-123705) Acceleration Request
Dear Ms. Breslin:
Per the request of the Commission, and in connection with the Hemosense, Inc. (the “Company”) request for acceleration of the effective date of its pending registration statement, the Company acknowledges that:
•
Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/ James D. Merselis
Show Raw Text
CORRESP 1 filename1.htm Correspondence Filing HEMOSENSE, INC. 651 RIVER OAKS PARKWAY SAN JOSE, CA 95134 June 13, 2005 Via EDGAR Transmission and Facsimile Securities and Exchange Commission Division of Corporation Finance Mail Stop 6010 100 F Street, NE Washington, DC 20549 Fax: (202) 772-9218 Attention: Mary Beth Breslin Re: HemoSense, Inc. (File No. 333-123705) Acceleration Request Dear Ms. Breslin: Per the request of the Commission, and in connection with the Hemosense, Inc. (the “Company”) request for acceleration of the effective date of its pending registration statement, the Company acknowledges that: • Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, /s/ James D. Merselis James D. Merselis President and Chief Executive Officer cc: David J. Saul David W. Pollak